target,target_id,target_uniprot,target_species,ligand,ligand_id,ligand_species,ligand_pubchem_cid,smiles,inchi,inchikey,type,action,action_comment,endogenous,primary_target,concentration_range,affinity_parameter,affinity_high,affinity_median,affinity_low,original_affinity_units,original_affinity_low_nm,original_affinity_median_nm,original_affinity_high_nm,original_affinity_relation,assay_description,receptor_site,ligand_context,pubmed_id HCN3,402,Q9P1Z3,Human,cilobradine,2355,,9869877,COc1ccc(cc1OC)CCN1CCC[C@@H](C1)CN1CCc2c(CC1=O)cc(c(c2)OC)OC,"InChI=1S/C28H38N2O5/c1-32-24-8-7-20(14-25(24)33-2)9-12-29-11-5-6-21(18-29)19-30-13-10-22-15-26(34-3)27(35-4)16-23(22)17-28(30)31/h7-8,14-16,21H,5-6,9-13,17-19H2,1-4H3/t21-/m0/s1",OBUFMJDDZTXJPY-NRFANRHFSA-N,Channel blocker,Antagonist,,,,,pIC50,,6.0,,,,,,,,,,16387796, HCN3,402,Q9P1Z3,Human,Cs+,2356,,104967,,,,Channel blocker,Antagonist,,,,,pIC50,,3.8,,IC50,,157000.0,,=,,,,16043489, HCN3,402,Q9P1Z3,Human,ivabradine,2357,,132999,COc1cc2C[C@@H](c2cc1OC)CN(CCCN1CCc2c(CC1=O)cc(c(c2)OC)OC)C,"InChI=1S/C27H36N2O5/c1-28(17-21-11-20-14-25(33-4)26(34-5)16-22(20)21)8-6-9-29-10-7-18-12-23(31-2)24(32-3)13-19(18)15-27(29)30/h12-14,16,21H,6-11,15,17H2,1-5H3/t21-/m1/s1",ACRHBAYQBXXRTO-OAQYLSRUSA-N,Channel blocker,Antagonist,,,,,pIC50,,5.7,,IC50,,2250.0,,=,,,,16387796, HCN3,402,Q9P1Z3,Human,zatebradine,2358,,65637,COc1ccc(cc1OC)CCN(CCCN1CCc2c(CC1=O)cc(c(c2)OC)OC)C,"InChI=1S/C26H36N2O5/c1-27(13-9-19-7-8-22(30-2)23(15-19)31-3)11-6-12-28-14-10-20-16-24(32-4)25(33-5)17-21(20)18-26(28)29/h7-8,15-17H,6,9-14,18H2,1-5H3",KEDQCFRVSHYKLR-UHFFFAOYSA-N,Channel blocker,Antagonist,,,,,pIC50,,5.7,,,,,,,,,,16387796, HCN3,402,Q9P1Z3,Human,ZD7288,2359,,123984,CCN(c1cc(=NC)n(c(n1)C)C)c1ccccc1,"InChI=1S/C15H20N4/c1-5-19(13-9-7-6-8-10-13)15-11-14(16-3)18(4)12(2)17-15/h6-11H,5H2,1-4H3",JABSKGQQWUDVRU-UHFFFAOYSA-N,Channel blocker,Antagonist,,,,,pIC50,,4.5,,IC50,,34000.0,,=,,,,16043489,